إعلان
إعلان
BBLG
Bone Biologics Corp Common Stock
1.60
USDبرعاية
+0.05
+3.55%
٠٩ يناير, ١٥:٥٢ UTC -5
مغلق
بعد الإغلاق
1.61
+0.01
+0.62%
تقارير أرباح BBLG
النسبة الإيجابية المفاجئة
BBLG تفوق 12 من 15 آخر التقديرات.
80%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.34
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-8.11%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-90.76%
Bone Biologics Corp Common Stock earnings per share and revenue
On ١٤ نوفمبر ٢٠٢٥, BBLG reported earnings of -0.37 USD per share (EPS) for Q3 25, beating the estimate of -1.25 USD, resulting in a 70.51% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.69% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an نقصان of -8.11% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Bone Biologics Corp Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Bone Biologics Corp Common Stock reported EPS of -$0.37, beating estimates by 70.51%, and revenue of $0.00, 0% as expectations.
How did the market react to Bone Biologics Corp Common Stock's Q3 2025 earnings?
The stock price moved up 1.69%, changed from $1.60 before the earnings release to $1.63 the day after.
When is Bone Biologics Corp Common Stock expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Bone Biologics Corp Common Stock's next earnings report?
Based on 3
المحللين, Bone Biologics Corp Common Stock is expected to report EPS of -$0.34 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان